ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
Osmotica Pharmaceuticals PLC

Osmotica Pharmaceuticals PLC (OSMT)

1,11
0,00
(0,00%)
Fermé 25 Décembre 10:00PM
0,00
0,00
(0,00%)
Après les heures de négociation: -

Outils de qualité professionnelle, pour des investisseurs individuels.

Statistiques et détails clés

Dernier
1,11
Prix Achat
1,09
Prix Vente
1,15
Volume échangé
-
0,00 Fourchette du Jour 0,00
0,00 Plage de 52 semaines 0,00
Clôture Veille
1,11
Ouverture
-
Dernière Transaction
Dernière heure de transaction
Volume moyen (3 m)
-
Volume financier
-
VWAP
-

OSMT Dernières nouvelles

UPDATE – Osmotica Pharmaceuticals plc Announces Corporate Name Change to RVL Pharmaceuticals plc, New Ticker Symbol “RVLP,” Plans to Launch UPNEEQ® into the Medical Aesthetics Market, and Provides Fourth Quarter 2022 Net Sales Guidance

-- Fourth Quarter 2021 net sales for UPNEEQ grew by approximately 41% to $3.1 million compared to the third quarter 2021 -- -- Fourth Quarter 2022 net sales for UPNEEQ targeted to range from...

Osmotica Pharmaceuticals plc Announces Corporate Name Change to RVL Pharmaceuticals plc, New Ticker Symbol “RVLP,” Plans to Launch UPNEEQ® into the Medical Aesthetics Market, and Provides Fourth Quarter 2022 Net Sales Guidance

-- Fourth Quarter 2021 net sales for UPNEEQ grew by approximately 41% to $3.1 million compared to the third quarter 2021 -- -- Fourth Quarter 2022 net sales for UPNEEQ targeted to range from...

RVL Pharmaceuticals to Host UPNEEQ® Overview and Business Update Webcast on January 19, 2022

-- Topics include corporate name change, launch plans into the medical aesthetics market and general business updates -- -- Featured speakers include Dr. Jackie Yee and Dr. Justin Harper...

Osmotica Pharmaceuticals plc to Host UPNEEQ® Overview and Business Update Call on January 19, 2022

BRIDGEWATER, N.J., Jan. 06, 2022 (GLOBE NEWSWIRE) -- Osmotica Pharmaceuticals plc (Nasdaq: OSMT) (“Osmotica” or the “Company”), a specialty pharmaceutical company, announced today that Brian...

Osmotica Pharmaceuticals plc to Present at H.C. Wainwright Bioconnect Conference

BRIDGEWATER, N.J., Dec. 20, 2021 (GLOBE NEWSWIRE) -- Osmotica Pharmaceuticals plc (Nasdaq: OSMT) (“Osmotica” or the “Company”), a specialty pharmaceutical company, announced today that Brian...

Osmotica Pharmaceuticals plc Reports Third Quarter 2021 Results and Provides Business Update

Third quarter Upneeq® product sales of $2.2 million, representing 47% growth over second quarter sales Expansion of Upneeq launch continues with introduction of Direct Dispense program in eyecare...

Osmotica Pharmaceuticals plc to Present at Jefferies London Virtual Healthcare Conference 2021

BRIDGEWATER, N.J., Nov. 15, 2021 (GLOBE NEWSWIRE) -- Osmotica Pharmaceuticals plc (Nasdaq: OSMT) (“Osmotica” or the “Company”), a specialty pharmaceutical company, announced today that Brian...

Osmotica Pharmaceuticals plc to Provide Third Quarter 2021 Business and Financial Update on November 15, 2021

BRIDGEWATER, N.J., Nov. 11, 2021 (GLOBE NEWSWIRE) -- Osmotica Pharmaceuticals plc (Nasdaq: OSMT) (“Osmotica” or the “Company”), a specialty pharmaceutical company, today announced that the...

Osmotica Pharmaceuticals plc Announces Closing of $35 Million Underwritten Public Offering

BRIDGEWATER, N.J., Oct. 13, 2021 (GLOBE NEWSWIRE) -- Osmotica Pharmaceuticals plc (Nasdaq: OSMT) (“Osmotica” or the “Company”), a specialty pharmaceutical company, today announced that on...

Osmotica Pharmaceuticals plc Announces Debt Financing from Athyrium Capital Management of up to $100 Million

BRIDGEWATER, N.J., Oct. 07, 2021 (GLOBE NEWSWIRE) -- Osmotica Pharmaceuticals plc (Nasdaq: OSMT) (“Osmotica” or the “Company”), a specialty pharmaceutical company, today announced that it has...

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

OSMT - Frequently Asked Questions (FAQ)

What is the current Osmotica Pharmaceuticals share price?
The current share price of Osmotica Pharmaceuticals is US$ 1,11
What is the 1 year trading range for Osmotica Pharmaceuticals share price?
Osmotica Pharmaceuticals has traded in the range of US$ 0,00 to US$ 0,00 during the past year

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
BAOSBaosheng Media Group Holdings Ltd
US$ 7,10
(310,40%)
58,74M
HOURHour Loop Inc
US$ 4,40
(207,69%)
97,42M
GTIGraphjet Technology
US$ 0,61
(168,72%)
265,48M
CREVCarbon Revolution Public Ltd
US$ 9,16
(135,48%)
26,95M
AVGRAvinger Inc
US$ 1,45
(125,72%)
107,53M
SLGLSol Gel Technologies Ltd
US$ 0,9798
(-40,62%)
3,07M
DRCTDirect Digital Holdings Inc
US$ 3,71
(-32,55%)
23,82M
CHEKCheck Cap Ltd
US$ 1,55
(-31,11%)
3,49M
SYTASiyata Mobile Inc
US$ 0,5178
(-30,83%)
2,63M
BTFValkyrie ETF Trust II CoinShares Bitcoin and Ether Stratagy ETF
US$ 15,47
(-30,38%)
147,98k
SVMHSRIVARU Holding Ltd
US$ 0,0338
(20,71%)
280,27M
GTIGraphjet Technology
US$ 0,61
(168,72%)
265,48M
LITMSnow Lake Resources Ltd
US$ 0,5849
(52,84%)
181,22M
LCIDLucid Group Inc
US$ 3,20
(3,23%)
108,75M
RGTIRigetti Computing Inc
US$ 11,35
(3,56%)
108,38M
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées